# Mulberry Biotherapeutics, Inc. — Form D

Mulberry Biotherapeutics, Inc. of WELLESLEY, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-04-30. The offering totals $2.8M, of which $2.1M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2021-04-30
- Form: D
- Accession: 0001859602-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.8M
- Amount sold: $2.1M
- Remaining: $686K
- Investors: 17
- Date of first sale: 2021-04-19
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-397742

## Issuer

- Name: Mulberry Biotherapeutics, Inc.
- CIK: 0001859602
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 40 WALNUT STREET, SUITE 301, WELLESLEY, MA, 02481
- Phone: 617-800-3415

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| Philip R Reilly | Director | Wellesley, MA |
| Neil R Kirby | Executive Officer | Wellesley, MA |
| Susan Luo | Executive Officer | Wellesley, MA |

## More

- [CIK 1859602 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1859602&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001859602-21-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.